Genomic Health Inc. | PressReleasePoint

Status message

SESSION['ACCESSGRANTED'] value is

Post date	Title	Picture
Mon, 01/07/2019 - 04:10	Genomic Health Marks More than 1 Million Patients Worldwide Who Have Benefited from Oncotype DX Testing in Personalizing Cancer Treatment Decisions to Improve Outcomes	Exact Sciences
Wed, 12/19/2018 - 07:11	NICE Expands Recommendation for the Oncotype DX Breast Recurrence Score Test to More Patients with Early-Stage Breast Cancer Within the United Kingdom	Exact Sciences
Tue, 12/18/2018 - 04:51	Genomic Health to Present at the 37th Annual J.P. Morgan Healthcare Conference	Exact Sciences
Wed, 12/05/2018 - 19:45	Black Women Have Worse Breast Cancer Outcomes Despite Receiving Similar Treatment as White Women	American Associ...
Mon, 12/03/2018 - 07:43	Genomic Health and Biocartis Expand Collaboration to Urology with the Development of an Idylla Oncotype DX Genomic Prostate Score Test	Exact Sciences
Mon, 11/19/2018 - 18:02	Genomic Health Announces Presentation of Two Large Studies at the 2018 San Antonio Breast Cancer Symposium, Reinforcing Real-world Value of the Oncotype DX Breast Recurrence Score Test	Exact Sciences
Thu, 11/08/2018 - 02:11	Genomic Health to Present at the 2018 Canaccord Genuity Medical Technologies & Diagnostics Forum	Exact Sciences
Mon, 10/29/2018 - 14:52	Medicare Establishes Final Local Coverage Determination (LCD) for Use of the Oncotype DX AR-V7 Nucleus Detect Test in Patients with Metastatic Castrate Resistant Prostate Cancer, Effective	Epic Sciences
Mon, 10/29/2018 - 07:33	Medicare Establishes Final Local Coverage Determination (LCD) for Use of the Oncotype DX AR-V7 Nucleus Detect Test in Patients with Metastatic Castrate Resistant Prostate Cancer Effective	Exact Sciences
Mon, 10/22/2018 - 08:58	Genomic Health Announces Multiple Studies Reinforcing Value of Oncotype DX Tests in Guiding Treatment for Breast and Prostate Cancer Patients	Exact Sciences
Tue, 10/09/2018 - 12:11	New NCCN Breast Cancer Guidelines Elevate Oncotype DX Breast Recurrence Score as the Only Preferred Multi-gene Test to Predict Chemotherapy Treatment	Exact Sciences
Thu, 09/27/2018 - 21:33	New Published Data and Recent Positive Private Payor Coverage Decisions Underscore Value and Utility of the Oncotype DX Genomic Prostate Score (GPS) Test	Exact Sciences
Wed, 09/12/2018 - 00:34	Epic Sciences Announces Completion of $52 Million Series E Financing	Epic Sciences
Fri, 09/07/2018 - 18:25	German Health Technology Assessment Body (IQWiG) Concludes Only Oncotype DX has Sufficient Evidence to Guide Breast Cancer Adjuvant Chemotherapy Decisions Based on Landmark TAILORx Study Results	Exact Sciences
Thu, 06/28/2018 - 16:31	Blood Test Predicts Treatment Response and Survival for Patients with Metastatic Prostate Cancer	Epic Sciences
Sun, 06/03/2018 - 11:29	TAILORx trial finds most women with early breast cancer do not benefit from chemotherapy	NIH
Wed, 05/30/2018 - 10:08	Genomic Health to Present at Jefferies 2018 Global Healthcare Conference	Exact Sciences
Mon, 05/21/2018 - 06:38	New Data Reinforce Positive Impact of the Oncotype DX Genomic Prostate Score Test in Guiding Treatment Decisions	Exact Sciences
Wed, 05/09/2018 - 03:59	Genomic Health to Present at Bank of America Merrill Lynch 2018 Health Care Conference	Exact Sciences
Thu, 04/26/2018 - 03:38	Large Independent Study Using the Oncotype DX Test Accepted for Presentation at 2018 American Society of Clinical Oncology (ASCO) Annual Meeting	Exact Sciences
Thu, 03/15/2018 - 06:35	Landmark TAILORx Results Aid in Assessing the Effect of Chemotherapy in Women with Early-stage Breast Cancer and Oncotype DX Breast Recurrence Score Results of 11 to 25	Exact Sciences
Mon, 02/26/2018 - 04:56	Genomic Health Expands Offering to Prostate Cancer Patients with Launch of Oncotype DX AR-V7 Nucleus Detect Test to Predict Treatment Response in Metastatic Disease	Exact Sciences
Mon, 02/05/2018 - 05:10	Oncotype DX Genomic Prostate Score Test Increases Use of Active Surveillance by 30 Percent in Low-risk Patients, Resulting in Greater Adherence to Guideline-based Care	Exact Sciences
Thu, 12/21/2017 - 06:13	Genomic Health to Present at the 36th Annual J.P. Morgan Healthcare Conference	Exact Sciences
Mon, 12/11/2017 - 07:09	Genomic Health Presents New Data Demonstrating Value of Oncotype DX to Optimize Breast Cancer Outcomes and Reduce Treatment Burden throughout Disease Continuum	Exact Sciences

Genomic Health Inc. Press Release

Status message